Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with covid-19: a review of immunosuppressant adjustment strategies

HIGHLIGHTS

• who: . et al. from the Shiraz University of Medical Sciences, Iran have published the research work: Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies, in the Journal: (JOURNAL) of 22/Dec/2021
• what: The authors focused on the use and monitoring of tacrolimus during NR therapy.
• future: Clinical studies are needed to explore the most appropriate strategy for these drugs with NR in transplant patients. Clinical studies are needed to better understand the optimal use of NR in this population. on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.